Atai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trial

reuters.com/business/healthcare-pharmaceuticals/atai-life-sciences-schizophrenia-drug-fails-meet-main-goal-mid-stage-trial-2025-07-25

This story appeared on reuters.com, 2025-07-25 20:17:10.741000.
The Entire Business World on a Single Page. Free to Use →